TY - STD TI - WHO. Global Tuberculosis Report. 2014. ID - ref1 ER - TY - JOUR AU - Corbett, E. L. AU - Watt, C. J. AU - Walker, N. AU - Maher, D. AU - Williams, B. G. AU - Raviglione, M. C. PY - 2003 DA - 2003// TI - The growing burden of tuberculosis: global trends and interactions with the HIV epidemic JO - Arch Intern Med VL - 163 UR - https://doi.org/10.1001/archinte.163.9.1009 DO - 10.1001/archinte.163.9.1009 ID - Corbett2003 ER - TY - JOUR AU - Cohen, K. AU - Meintjes, G. PY - 2010 DA - 2010// TI - Management of individuals requiring antiretroviral therapy and TB treatment JO - Curr Opin HIV AIDS. VL - 5 UR - https://doi.org/10.1097/COH.0b013e3283339309 DO - 10.1097/COH.0b013e3283339309 ID - Cohen2010 ER - TY - JOUR AU - Shankar, E. M. AU - Vignesh, R. AU - Ellegard, R. AU - Barathan, M. AU - Chong, Y. K. AU - Bador, M. K. PY - 2014 DA - 2014// TI - HIV-Mycobacterium tuberculosis co-infection: a ‘danger-couple model’ of disease pathogenesis JO - Pathog Dis. VL - 70 UR - https://doi.org/10.1111/2049-632X.12108 DO - 10.1111/2049-632X.12108 ID - Shankar2014 ER - TY - JOUR AU - Naidoo, P. AU - Peltzer, K. AU - Louw, J. AU - Matseke, G. AU - McHunu, G. AU - Tutshana, B. PY - 2013 DA - 2013// TI - Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study JO - BMC Public Health. VL - 13 UR - https://doi.org/10.1186/1471-2458-13-396 DO - 10.1186/1471-2458-13-396 ID - Naidoo2013 ER - TY - JOUR AU - Castelnuovo, B. AU - Nsumba, M. AU - Musomba, R. AU - Kaimal, A. AU - Lwanga, I. AU - Kambugu, A. PY - 2015 DA - 2015// TI - Strengthening the “viral failure pathway”: clinical decision and outcomes of patients with confirmed viral failure in a large HIV care clinic in Uganda JO - J Acquir Immune Defic Syndr VL - 70 UR - https://doi.org/10.1097/QAI.0000000000000820 DO - 10.1097/QAI.0000000000000820 ID - Castelnuovo2015 ER - TY - STD TI - WHO. Consolidated Guidelines ARV, chapter 7. 2013. ID - ref7 ER - TY - JOUR AU - Rutherford, G. W. AU - Anglemyer, A. AU - Easterbrook, P. J. AU - Horvath, T. AU - Vitoria, M. AU - Penazzato, M. PY - 2014 DA - 2014// TI - Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure JO - AIDS. VL - 28 UR - https://doi.org/10.1097/QAD.0000000000000236 DO - 10.1097/QAD.0000000000000236 ID - Rutherford2014 ER - TY - JOUR AU - Bell, L. C. AU - Breen, R. AU - Miller, R. F. AU - Noursadeghi, M. AU - Lipman, M. PY - 2015 DA - 2015// TI - Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis JO - Int J Infect Dis. VL - 32 UR - https://doi.org/10.1016/j.ijid.2014.12.030 DO - 10.1016/j.ijid.2014.12.030 ID - Bell2015 ER - TY - JOUR AU - Ezeamama, A. E. AU - Mupere, E. AU - Oloya, J. AU - Martinez, L. AU - Kakaire, R. AU - Yin, X. PY - 2015 DA - 2015// TI - Age, sex, and nutritional status modify the CD4 + T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapy JO - Int J Infect Dis. VL - 35 UR - https://doi.org/10.1016/j.ijid.2015.04.008 DO - 10.1016/j.ijid.2015.04.008 ID - Ezeamama2015 ER - TY - JOUR AU - Gupta, R. K. AU - Brown, A. E. AU - Zenner, D. AU - Rice, B. AU - Yin, Z. AU - Thomas, H. L. PY - 2015 DA - 2015// TI - CD4 + cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection JO - AIDS. VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000685 DO - 10.1097/QAD.0000000000000685 ID - Gupta2015 ER - TY - JOUR AU - Havlir, D. V. AU - Kendall, M. A. AU - Ive, P. AU - Kumwenda, J. AU - Swindells, S. AU - Qasba, S. S. PY - 2011 DA - 2011// TI - Timing of antiretroviral therapy for HIV-1 infection and tuberculosis JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1013607 DO - 10.1056/NEJMoa1013607 ID - Havlir2011 ER - TY - JOUR AU - Hermans, S. M. AU - Castelnuovo, B. AU - Katabira, C. AU - Mbidde, P. AU - Lange, J. M. AU - Hoepelman, A. I. PY - 2012 DA - 2012// TI - Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda JO - J Acquir Immune Defic Syndr VL - 60 UR - https://doi.org/10.1097/QAI.0b013e318251aeb4 DO - 10.1097/QAI.0b013e318251aeb4 ID - Hermans2012 ER - TY - STD TI - WHO. Guidelines for treatment of tuberculosis. 4th ed. 2010. ID - ref14 ER - TY - JOUR AU - Rajesh, L. AU - Karunaianantham, R. AU - Narayanan, P. R. AU - Swaminathan, S. PY - 2009 DA - 2009// TI - Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients JO - AIDS Res Hum Retroviruses VL - 25 UR - https://doi.org/10.1089/aid.2009.0110 DO - 10.1089/aid.2009.0110 ID - Rajesh2009 ER - TY - JOUR AU - Sinha, S. AU - Raghunandan, P. AU - Chandrashekhar, R. AU - Sharma, S. K. AU - Kumar, S. AU - Dhooria, S. PY - 2013 DA - 2013// TI - Nevirapine versus efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and tuberculosis infections in India: a pilot study JO - BMC Infect Dis VL - 13 UR - https://doi.org/10.1186/1471-2334-13-482 DO - 10.1186/1471-2334-13-482 ID - Sinha2013 ER - TY - BOOK AU - Braun, A. AU - Scherrer, A. U. AU - Sekaggya, C. AU - Kirangwa, J. AU - Ssemwanga, D. AU - Kaleebu, P. AU - Günthard, H. AU - Kambugu, A. AU - Castelnuovo, B. AU - Fehr, J. PY - 2016 DA - 2016// TI - High rates of multi class drug resistance in HIV-1 infected individuals monitored with CD4 count in Uganda PB - Abstract CY - HIV Glasgow ID - Braun2016 ER - TY - JOUR AU - Maggiolo, F. PY - 2009 DA - 2009// TI - Efavirenz: a decade of clinical experience in the treatment of HIV JO - J Antimicrob Chemother VL - 64 UR - https://doi.org/10.1093/jac/dkp334 DO - 10.1093/jac/dkp334 ID - Maggiolo2009 ER - TY - JOUR AU - Breen, R. A. AU - Swaden, L. AU - Ballinger, J. AU - Lipman, M. C. PY - 2006 DA - 2006// TI - Tuberculosis and HIV co-infection: a practical therapeutic approach JO - Drugs. VL - 66 UR - https://doi.org/10.2165/00003495-200666180-00003 DO - 10.2165/00003495-200666180-00003 ID - Breen2006 ER - TY - JOUR AU - Manosuthi, W. AU - Sukasem, C. AU - Lueangniyomkul, A. AU - Mankatitham, W. AU - Thongyen, S. AU - Nilkamhang, S. PY - 2014 DA - 2014// TI - CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy JO - Int J Antimicrob Agents VL - 43 UR - https://doi.org/10.1016/j.ijantimicag.2013.10.022 DO - 10.1016/j.ijantimicag.2013.10.022 ID - Manosuthi2014 ER - TY - JOUR AU - Barter, D. M. AU - Agboola, S. O. AU - Murray, M. B. AU - Barnighausen, T. PY - 2012 DA - 2012// TI - Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa—a systematic review JO - BMC Public Health. VL - 12 UR - https://doi.org/10.1186/1471-2458-12-980 DO - 10.1186/1471-2458-12-980 ID - Barter2012 ER - TY - JOUR AU - Lee, G. Q. AU - Bangsberg, D. R. AU - Muzoora, C. AU - Boum, Y. AU - Oyugi, J. H. AU - Emenyonu, N. PY - 2014 DA - 2014// TI - Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda JO - AIDS Res Hum Retroviruses VL - 30 UR - https://doi.org/10.1089/aid.2014.0043 DO - 10.1089/aid.2014.0043 ID - Lee2014 ER -